Reference
Tierney A, et al. IgG4-Related Disease as an Autoimmune Consequence of Alemtuzumab Therapy for Management of Multiple Sclerosis. Neurology 98 (Suppl.): No. 18, May 2022. Available from: URL: https://www.neurology.org/ [abstract]
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1917, 31 (2022). https://doi.org/10.1007/s40278-022-19902-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-19902-7